Fr. 57.50

Biomarkers Diagnostic Approach - An Update. DE

English · Paperback / Softback

Shipping usually within 2 to 3 weeks (title will be printed to order)

Description

Read more

Oral squamous cell carcinomas can develop in various anatomical sites and has a variable biological behaviour. Tumor markers hold the promise of a revolution in disease diagnosis and therapeutic monitoring, provided that major challenges in genomics, proteomics and related disciplines can be addressed. The regulatory standards to be met by new measurement technologies for the clinical laboratory are very high. The measurements must not only be accurate, they must have a concrete medical implication. A more sophisticated understanding of the pathogenesis and the identification of better biological markers could provide useful information for predicting outcome and individualizing treatment.

About the author










Dott.ssa Avani Patel - Professore assistente - Patologia orale e maxillo-facciale e Microbiologia orale presso il Narsinhbhai Patel Dental College & Hospital, Sankalchand Patel University, Visnagar. Gujarat.Dr. Shylaja- Professore e responsabile di Patologia orale e maxillo-facciale e Microbiologia orale.Dr. Reena - Professore associato - Patologia orale e maxillo-facciale e microbiologia orale.

Product details

Authors Dr. Shylaja Attur, Shylaja Attur, Dr. Reena Chaudhary, Reena Chaudhary, Avani Patel, Dr. Avani Patel
Publisher LAP Lambert Academic Publishing
 
Languages English
Product format Paperback / Softback
Released 08.08.2022
 
EAN 9786205492109
ISBN 9786205492109
No. of pages 56
Subject Natural sciences, medicine, IT, technology > Medicine > Dentistry

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.